Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,452,897
+$1,194,977 QoQ
Shares Held
41,158
+8.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.06%
of 13F equity value
Holder Rank
#1,087
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hollow Brook Wealth Management LLC holds $18,211,815 across 8 Drug Manufacturers - General names. JNJ ranks #1 (57.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
41,158 | $10,452,897 | |
| 2 | PFE |
Pfizer Inc
|
196,805 | $4,739,064 | |
| 3 | ABBV |
AbbVie Inc.
|
2,525 | $635,391 | |
| 4 | NVS |
Novartis AG
|
3,788 | $593,655 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,113 | $528,520 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,546 | $448,001 | |
| 7 | AMGN |
Amgen Inc
|
1,202 | $435,268 | |
| 8 | LLY |
ELI LILLY & Co
|
316 | $379,019 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,452,897 | 41,158 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,257,920 | 37,874 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,442,939 | 40,797 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,523,482 | 62,148 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,556,040 | 62,560 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,301,151 | 62,115 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,164,280 | 63,368 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,949,853 | 49,055 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,201,303 | 49,270 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,947,944 | 37,600 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,594,053 | 48,450 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $7,814,444 | 50,173 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,286,427 | 50,063 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,669,555 | 49,481 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $8,251,144 | 46,709 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,558,667 | 46,270 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $8,126,762 | 45,782 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $8,187,494 | 46,197 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,003,414 | 52,630 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,587,431 | 46,981 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,856,780 | 47,692 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,944,185 | 48,337 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,591,066 | 48,234 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,293,184 | 48,987 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,136,249 | 43,634 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,701,007 | 43,476 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||